CCL18 and non-small cell lung carcinoma: Notably, serum CCL18 levels are significantly elevated in non-small cell lung cancer (NSCLC) patients and exhibit a negative correlation with both prognosis and overall survival (167–169), suggesting its key role as a tumor-promoting chemokine.